Home
Anthem Biosciences PE Ratio

Anthem Biosciences Ltd
NSE: ANTHEM
PE
Key Highlights
- The P/E Ratio of Anthem Biosciences Ltd is 90.8 as of 21 Jul 25 .
- The P/E Ratio of Anthem Biosciences Ltd changed from 0 on March 2021 to 0 on March 2023 . This represents a CAGR of 0.0% over 3 years.
- The Latest Trading Price of Anthem Biosciences Ltd is ₹ 730.35 as of 21 Jul 15:30 .
- The PE Ratio of Pharmaceuticals Industry has changed from 21.1 to 40.1 in 5 years. This represents a CAGR of 13.70%.
- The PE Ratio of Automobile industry is 16.9. The PE Ratio of Finance industry is 27.1. The PE Ratio of IT - Software industry is 27.0. The PE Ratio of Pharmaceuticals industry is 34.3. The PE Ratio of Retail industry is 109.6. The PE Ratio of Textiles industry is 24.5 in 2025.
Historical P/E Ratio of Anthem Biosciences Ltd
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
Historical P/E Ratio of Anthem Biosciences Ltd
Company Fundamentals for Anthem Biosciences Ltd

Anthem Biosciences Ltd
NSE: ANTHEM
Share Price
Market Price of Anthem Biosciences Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
21 Jul 2025 | 730.35 |
BlinkX Score for Anthem Biosciences Ltd
Asset Value vs Market Value of Anthem Biosciences Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
PE Ratio of Anthem Biosciences Ltd Explained
₹41017
Market cap
₹374
Earnings
81.1X
PE Ratio
PE Ratio of Pharmaceuticals Industry over time
PE Ratio of Top Sectors
Historical Market Cap of Anthem Biosciences Ltd
Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore
Historical Market Cap of Anthem Biosciences Ltd
Historical Revenue, EBITDA and Net Profit of Anthem Biosciences Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Revenue, EBITDA and Net Profit of Anthem Biosciences Ltd
Revenue
EBITDA
Net Profit
Historical Dividend Payout of Anthem Biosciences Ltd
Dividend payout refers to the total dividends paid to shareholders relative to the company's earnings. It is a financial measure that determines the percentage of earnings paid out to existing shareholders as dividends. How to calculate Dividend Payout Ratio? The dividend payout ratio formula is as follows: DPR = Dividends paid / Net earnings With the dividend payout ratio, you can understand the company's priorities. It is an important metric that allows you to easily check DPR online.
Historical Dividend Payout of Anthem Biosciences Ltd
About Anthem Biosciences Ltd
- Anthem Biosciences Limited was originally incorporated as 'Anthem Biosciences Private Limited', dated June 13, 2006, issued by RoC. Subsequently, Company was converted from a Private Company to a Public Company , followed by the change in name of the Company to 'Anthem Biosciences Limited' and a Certificate of Incorporation upon the conversion was issued by RoC on December 10, 2024. The Company has been set up as a Life sciences/ Biotechnology based venture specialising in the manufacture of catalytic preparation, other organic compounds such as speciality organic molecules, biologically active peptides etc., which are high-value products used in drug, agrochemical and speciality chemicals industries. The Company started operations at Unit I and set up a Custom Synthesis Plant with a capacity of 6 KL in year 2007.
Anthem Biosciences Ltd News Hub
Anthem Biosciences IPO ends with 63.86x subscription
The initial public offer of Anthem Biosciences received bids for 2,81,45,24,128 shares as against 4,
Read more
17 Jul 25
Anthem Biosciences IPO subscribed 73%
The initial public offer of Anthem Biosciences received bids for 32,113,406 shares as against 44,070
Read more
14 Jul 25
Anthem Biosciences IPO subscribed 3.28 times
The initial public offer of Anthem Biosciences received bids for 14,47,66,596 shares as against 4,40
Read more
15 Jul 25
Anthem Biosciences jumps on debut
The scrip was listed at Rs 723.10, exhibiting a premium of 26.86% to the issue price. So far, the st
Read more
21 Jul 25